Director of Quality (Head of Quality)
PHARMALOGIC HOLDINGS
Summary
The Director of Quality serves as the Head of Quality for PharmaLogic's newly acquired therapeutics business, leading the quality organization and establishing the systems, capabilities, and culture needed for reliable GMP manufacturing. This leader is accountable for the pharmaceutical quality system and Quality oversight of sterile therapeutic drug manufacturing, testing, and release under applicable 21 CFR Parts 210 and 211 requirements. As a member of the site leadership team, the Director partners with Operations, Technical Operations, Regulatory Affairs, and corporate Quality to support clinical supply, technology transfer, commercialization, and growth.
Job description
Role Summary
The Director of Quality serves as the Head of Quality for PharmaLogic's newly acquired therapeutics business, leading the quality organization and establishing the systems, capabilities, and culture needed for reliable GMP manufacturing. This leader is accountable for the pharmaceutical quality system and Quality oversight of sterile therapeutic drug manufacturing, testing, and release under applicable 21 CFR Parts 210 and 211 requirements. As a member of the site leadership team, the Director partners with Operations, Technical Operations, Regulatory Affairs, and corporate Quality to support clinical supply, technology transfer, commercialization, and growth.
Quality Leadership and Governance
- Lead the Quality function, including Quality Assurance and oversight of Quality Control and microbiology activities within the assigned organizational scope.
- Set strategy, staffing, budgets, objectives, and development plans; build a capable team with clear accountability.
- Maintain the Quality unit's independent authority to approve or reject materials and drug products, including outsourced products; approve quality-impacting procedures and specifications; and ensure documented responsibilities and appropriate escalation to corporate Quality and executive leadership.
- Own batch disposition through authorized Quality personnel.
- Ensure production and laboratory records, deviations, and required test results receive appropriate review before release.
- Place materials or product on hold and stop affected operations when quality or compliance concerns warrant.
Quality Systems and Sterile Manufacturing
- Establish and continuously improve systems for deviations, investigations, corrective and preventive actions, change control, document control, training, complaints, product quality reviews, and quality risk management.
- Require scientifically sound root-cause analysis and verification of CAPA effectiveness.
- Provide Quality oversight of aseptic processing and contamination control, including cleanrooms, environmental and personnel monitoring, gowning qualification, aseptic process simulations, sterilization, disinfection, and container closure integrity, as applicable.
- Oversee laboratory controls, specifications, analytical method validation and transfer, stability programs, and investigations of out-of-specification and out-of-trend results.
- Ensure complete, accurate, traceable data and effective controls for electronic records and computerized systems.
- Approve qualification and validation strategies, protocols, and reports for facilities, utilities, equipment, manufacturing processes, cleaning, and computerized systems.
- Ensure a documented lifecycle approach and continued process verification.
Manufacturing Readiness and External Partners
- Lead Quality readiness for new products, technology transfers, process scale-up, and commercial launches.
- Establish clear acceptance criteria and readiness decisions with Development, Manufacturing, Engineering, and Regulatory Affairs.
- Serve as the primary site Quality representative for FDA inspections and customer audits.
- Lead inspection preparation, responses, and commitments; maintain sustained readiness and timely, effective remediation.
- Manage supplier qualification, contract laboratory and manufacturer oversight, audits, and quality agreements.
- Define responsibilities with CDMO customers and ensure outsourced activities meet agreed quality requirements.
Acquisition Integration and Regulatory Partnership
- Lead the acquisition Quality integration plan: assess inherited systems and commitments, prioritize gaps by risk, align governance and procedures with corporate standards, and manage changes without disrupting compliant product supply.
- Partner with Regulatory Affairs on manufacturing and quality content for filings, change assessments, and regulatory commitments.
- Lead quality defect assessments and support recalls, field actions, and required notifications with designated functions.
- For radiopharmaceutical therapeutics, oversee appropriate controls for isotope and precursor quality, radiochemical testing, time-sensitive manufacturing and disposition, and stability.
- Partner with Radiation Safety and EHS on safe, compliant execution.
Quality Performance and Continuous Improvement
- Present quality performance and material risks to site and corporate leadership.
- Use management reviews and meaningful metrics to improve investigation quality, CAPA effectiveness, release reliability, training, and inspection readiness.
Leadership and Working Expectations
- A visible, hands-on leader who develops people, communicates clearly, and holds teams accountable.
- Able to challenge decisions constructively, escalate risks promptly, and make timely decisions under pressure.
- Regular onsite presence in manufacturing and laboratory areas, compliance with required gowning and safety practices, and availability for critical quality events are expected.
Requirements
- Bachelor's degree in chemistry, biology, microbiology, pharmacy, engineering, or a related scientific discipline
- Typically 10 or more years of progressive pharmaceutical Quality experience
- At least 5 years leading teams or major Quality programs in a GMP manufacturing environment
- Demonstrated Quality leadership in sterile injectable manufacturing
- Substantial knowledge of aseptic processing, contamination control, laboratory controls, validation, and data integrity
- Strong working knowledge of 21 CFR Parts 210 and 211, electronic records requirements, and relevant FDA guidance and ICH quality principles
- Experience leading regulatory inspections, complex investigations, remediation, and batch disposition
- Experience supporting technology transfer, clinical or commercial manufacturing, and cross-functional delivery of quality or operational improvements
- Preferred: experience with therapeutic radiopharmaceuticals or radioligand therapies
- Preferred: CDMO operations and pharmaceutical customer partnerships
- Preferred: commercial launch or preapproval inspection readiness
- Preferred: experience integrating an acquisition, building or transforming a quality organization, and implementing electronic quality management systems
- Preferred: advanced scientific degree or relevant professional certification
Company overview
PharmaLogic Holdings Corp. is a leading global contract development and manufacturing organization (CDMO) specializing in diagnostic and therapeutic radiopharmaceuticals. Founded in 1993 and headquartered in Boca Raton, Florida, the company operates a robust network of more than 45 facilities across the United States, Puerto Rico, Canada, and Norway. PharmaLogic provides comprehensive solutions spanning development, manufacturing, and distribution of both clinical and commercial-stage radiopharmaceutical products, adhering to the highest quality and regulatory standards. The company's rapidly expanding diagnostics business leverages advanced technologies to enhance patient access to novel diagnostics in oncology, cardiology, and Alzheimer's disease. In the therapeutic segment, PharmaLogic is recognized as the world's only cGMP-compliant CDMO currently manufacturing and distributing a commercial radiopharmaceutical therapeutic across more than 30 countries. With decades of industry expertise, PharmaLogic is dedicated to enabling global patient access to radiopharmaceuticals through strategic development partnerships with industry innovators, advancing the future of the field and supporting partners throughout the product lifecycle.